Loading ...
japan Nalidixic acid resistant salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacincausedtreatment failure
Rahman M. Nalidixic acid resistant Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacincausedtreatment failure
these therapeutics ... the development of drug resistancecausestreatment failure
a Neisseria gonorrhoeae strain with combined ceftriaxone and high - level azithromycin resistance , England , February 2018 7(passive) caused byGonorrhoea treatment failure
factors other than drug resistance(passive) can be caused byTreatment failure
drug resistance helppreventtreatment failures
factors other than direct drug resistance(passive) may be caused byTreatment failure
resistance to antibiotics(passive) caused bytreatment failure
to detect inducible clindamycin resistanceto preventtreatment failure
resistant bacteria(passive) caused byTreatment failure
drug resistance or a separate attack(passive) caused bytreatment failure
the development of antimicrobial resistance(passive) caused bytreatment failure
poor medication adherence(passive) caused byTreatment failure
the fixation of a single drug resistance mutation(passive) is caused bytreatment failure
orderto preventtreatment failure
viral resistance(passive) caused byTreatment failure
fluconazole resistancecausingtreatment failures
resistance to chemotherapy(passive) caused bytreatment failure
antifungal resistancecan causetreatment failure
chemotherapy resistance(passive) caused bytreatment failure
cisplatin resistancecausestreatment failure
resistance ... many antibioticscausetreatment failure
incorrect use of product , misdiagnosis of the original condition , or re - infestation(passive) may also be caused byTreatment failure
early treatment ... the most important factorpreventstreatment failure
antimicrobial resistance ( AMR ) and mastitis caused by other factors(passive) caused bytreatment failure
factors such as viral drug resistance , and difficulty with adherence to treatment(passive) caused bytreatment failure
obstruction in long - term intrathecal baclofen administration Objects(passive) caused bytreatment failure
to accurately detect minority variants conferring drug resistanceto preventtreatment failure
CYTOSTATICS h. Accelerated fractionation ( treating once per day on 6 to 7 days of the week or using a split - course treatment or a concomitant boostpreventstreatment failure interctions
the leakage of microorganisms and endotoxins , which leads to pathological lesions ( 9(passive) is caused byEndodontic treatment failure
The increase of antibiotic resistance to H. pyloricausesfailure of treatment
Vaginitis Finding the causepreventstreatment failure
a strain of USA300 community - associated methicillin - resistant Staphylococcus aureus ( MRSA ) with intermediate susceptibility to vancomycin and reduced susceptibility to daptomycin(passive) caused bytreatment failure
many factors , including the development of resistance or nonadherence(passive) can be caused byTreatment failure
Resistance to the first - line drugscausestreatment failure
Despite the great promise of targeted therapy , drug resistance is likely to developcausingtreatment failure
non - compliance(passive) caused bytreatment failure
2013 ) Differences in the mechanisms that induce obesity and metabolic syndrome in experimental animal models and humansmay causetreatment failure
OBJECTIVES ATP - Binding Cassette ( ABC ) transportersmay causetreatment failure
the development of resistance to cisplatin(passive) is frequently caused byTreatment failure
in relapse and deathresultingin relapse and death
to the death of the patientcould ... leadto the death of the patient
to illness and deathleadingto illness and death
to the death of the animalleadingto the death of the animal
to late deathcan contributeto late death
in local recurrence and deathresultingin local recurrence and death
to invasive ventilation or deathleadingto invasive ventilation or death
in MM relapse and patient deathresultingin MM relapse and patient death
to drug resistance or even deathleadingto drug resistance or even death
in readmission , death , or other significant morbidityresultingin readmission , death , or other significant morbidity
from toxicity , disease progression , or deathresultingfrom toxicity , disease progression , or death
in major cardiac problems or even deathresultingin major cardiac problems or even death
to death in the six 2003 MRSA / flu casesledto death in the six 2003 MRSA / flu cases
in death of > 90 % of patients with metastatic disease [ 10resultingin death of > 90 % of patients with metastatic disease [ 10
in longer illnesses , more severe symptoms and even deathmay resultin longer illnesses , more severe symptoms and even death
in death , chest discomfort , swellingPsychiatricCommon ( 1 % to 10 %resultingin death , chest discomfort , swellingPsychiatricCommon ( 1 % to 10 %
in death or resistance and transmission of resistant strains to other individualsresultingin death or resistance and transmission of resistant strains to other individuals
to increased short- or long - term morbidity , or even deathleadingto increased short- or long - term morbidity , or even death
the physician to reconsider the diagnosisshould promptthe physician to reconsider the diagnosis
in a prolonged illness for the patient with an increased risk of severe malaria and deathresultin a prolonged illness for the patient with an increased risk of severe malaria and death
in escalation of care during hospital admissionresultingin escalation of care during hospital admission
in escalation of care during the admissionresultedin escalation of care during the admission
in development of drug resistanceresultingin development of drug resistance
varicose veins from returning Temporary bruising , itching , pain , or blistering where the veins were treated Scarring resulting from ulcers or death of the tissue around the treated vein ( skin or fat necrosisto preventvaricose veins from returning Temporary bruising , itching , pain , or blistering where the veins were treated Scarring resulting from ulcers or death of the tissue around the treated vein ( skin or fat necrosis
in a low recovery rate and frequent relapses [ 5resultsin a low recovery rate and frequent relapses [ 5
alsocan ... resultalso
an early relapsecausingan early relapse
to progressively greater drug resistancehave ledto progressively greater drug resistance
from drug resistance or inadequate adherenceusually resultsfrom drug resistance or inadequate adherence
mostly from underestimation of the problem or insufficient treatment of existing instability and deformityresultmostly from underestimation of the problem or insufficient treatment of existing instability and deformity
to crossover to the other arm or discontinuation of the study protocol ( secondary outcomesleadingto crossover to the other arm or discontinuation of the study protocol ( secondary outcomes
to crossover to the other arm or discontinuation of the study protocol , and physiological variablesleadingto crossover to the other arm or discontinuation of the study protocol , and physiological variables
to the development of MDR - TB in case of the mono - drug and poly - drugs ( non - MDR ) resistant cases [ 26leadingto the development of MDR - TB in case of the mono - drug and poly - drugs ( non - MDR ) resistant cases [ 26
from sub therapeutic anticoagulation , or failure of anticoagulation despite adequate dosing , where serum assay data is available [ 5may resultfrom sub therapeutic anticoagulation , or failure of anticoagulation despite adequate dosing , where serum assay data is available [ 5
from inappropriate combination therapy with omeprazoleresultingfrom inappropriate combination therapy with omeprazole
from drug resistance , poor adherence or inadequate drug exposuremay resultfrom drug resistance , poor adherence or inadequate drug exposure
in HIV drug resistance [ 27–30resultingin HIV drug resistance [ 27–30
from drug resistance or inadequate exposure to the drugmay resultfrom drug resistance or inadequate exposure to the drug
to longer periods of infectivity , which increase the numbers of infected people moving in the community and thus expose the general population to the risk of contracting a resistant strain of infection Superbugs - New Strains of Antibiotic Resistant Bacteriaalso leadto longer periods of infectivity , which increase the numbers of infected people moving in the community and thus expose the general population to the risk of contracting a resistant strain of infection Superbugs - New Strains of Antibiotic Resistant Bacteria
from resistance of staphylococcus aureus to daptomycin windowresultingfrom resistance of staphylococcus aureus to daptomycin window